SEC Form 4 · accession 0001645627-17-000139
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 15, 2017
Accepted (ET)
Nov 17, 2017 · 1:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.048 | A | 24,192,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.048 | A | 24,195,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.0479 | A | 24,198,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.048 | A | 24,201,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.0479 | A | 24,204,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.0519 | A | 24,207,189 | D | |
| Common Stock | Nov 15, 2017 | P | 3,000 | $0.0511 | A | 24,210,189 | D | |
| Common Stock | Nov 16, 2017 | P | 3,000 | $0.049 | A | 24,213,189 | D | |
| Common Stock | Nov 16, 2017 | P | 3,000 | $0.0469 | A | 24,216,189 | D |
Table II — derivative securities
No Table II lines on this filing.